Marksans Pharma Limited has informed the Exchange about Certificate received from RTA under 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has submitted to the stock exchanges a certificate received from its Registrar and Transfer Agent, Bigshare Services Private Limited, under Regulation 74(5) of SEBI's Depositories and Participants Regulations. The certificate covers the quarter ended December 31, 2025. It confirms that all securities received from Depository Participants for dematerialization were processed (accepted or rejected) and reported back to the depositories within the required timeframe. It also confirms that physical share certificates received for demat were mutilated and cancelled, and the depository's name was substituted as the registered owner in the company's register of members within 15 days of receipt.
This is a routine quarterly compliance filing and has no direct impact on the company's financials, operations, or stock price. It simply affirms that the company's share dematerialization processes are functioning as required by SEBI regulations.